Company Profile
Evelo Biosciences Stock Price, News & Analysis
- Ticker:
- EVLO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Evelo Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
— USD (-100.00%)
Close
Last updated: June 18, 2026 at 00:00
—
Market cap
Why the stock is moving
EVLO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Evelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Evelo Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Evelo Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Evelo Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Evelo Biosciences do?
Evelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is EVLO stock listed?
Evelo Biosciences (EVLO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Evelo Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Evelo?
Evelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Evelo Biosciences targeting with Evelo?
Evelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Evelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.